Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Michigan Neural Distinctiveness project
ISRCTN17266136Phase 3Suspended
- Sponsor
- University of Michigan
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lorazepam (5 arms), sponsored by University of Michigan. Started Oct 2016; status: suspended.
02
Drugs
lorazepam
Beyond the preview
Go deeper on ISRCTN17266136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17266136.